SB589
To Create The 340b Program Transparency Act; And To Amend The Law Concerning Transparency And Accountability For Certain 340b-covered Entities.
Last Action (May 5, 2025): Died in Senate Committee at Sine Die adjournment.
Sponsors
AI-Generated Summary
Senate Bill 589, titled the '340B Program Transparency Act,' mandates that healthcare providers and hospitals in Arkansas participating in the federal 340B drug discount program report detailed financial and utilization data to the Arkansas Department of Health. Covered entities must annually disclose the total amount of savings realized through the program, a comprehensive accounting of how those savings are reinvested, and specific metrics regarding charity care, uncompensated care, and patient demographics. The bill requires these reports to include the allocation of funds toward administrative costs, patient assistance programs, and expansion of services in medically underserved areas. The Department of Health is tasked with developing standardized reporting forms and publishing the compiled reports on a public website. Failure to comply with these transparency requirements can result in administrative penalties of up to $500 per day, capped at $150,000 annually. The legislation also provides a mechanism for entities to protect trade secrets and proprietary data from public disclosure.
Potential Impact Analysis
Who Might Benefit?
The primary beneficiaries are state policymakers, regulatory agencies, and the general public, who gain increased access to data regarding how healthcare entities utilize federal drug discount savings. Additionally, patients and advocacy groups may benefit from greater transparency regarding charity care and the availability of healthcare services in underserved regions, which could theoretically influence public discourse and institutional accountability regarding the equitable distribution of these program benefits.
Who Might Suffer?
The primary groups negatively impacted are the 'covered entities'—typically hospitals and healthcare providers—that participate in the 340B program. These entities will face increased administrative burdens and costs associated with compiling, auditing, and submitting detailed annual reports to the state. Furthermore, they risk significant financial penalties for reporting deficiencies, and they may be concerned about the potential public exposure of sensitive business operations or proprietary financial strategies that, while not explicitly illegal, could be subject to scrutiny or competitive disadvantage.
Get Notified
Receive an email when this bill's status changes.